Arizona Medical Marijuana Certification Center - Just another MJ Certs Sites site
title
 
phone
Call us to see if you
qualify: 480-994-0420
Fax: 855-305-4152
youtube
 

Agitation of Alzheimer’s Disease

Alzheimer’s Disease (AD), also called Alzheimer disease, Senile Dementia of the Alzheimer Type (SDAT) or simply Alzheimer’s, is the most common form of dementia. This incurable, degenerative, and terminal disease was first described by German psychiatrist and neuropathologist Alois Alzheimer in 1906 and was named after him. Generally it is diagnosed in people over 65 years of age, although the less-prevalent early-onset Alzheimer’s can occur much earlier. An estimated 26.6 million people worldwide had Alzheimer’s in 2006; this number may quadruple by 2050.

Although each sufferer experiences Alzheimer’s in a unique way, there are many common symptoms. The earliest observable symptoms are often mistakenly thought to be ‘age-related’ concerns, or manifestations of stress. In the early stages, the most commonly recognised symptom is memory loss, such as difficulty in remembering recently learned facts. When a doctor or physician has been notified, and AD is suspected, the diagnosis is usually confirmed with behavioral assessments and cognitive tests, often followed by a brain scan if available. As the disease advances, symptoms include confusion, irritability and aggression, mood swings, language breakdown, long-term memory loss, and the general withdrawal of the sufferer as their senses decline. Gradually, bodily functions are lost, ultimately leading to death. Individual prognosis is difficult to assess, as the duration of the disease varies. AD develops for an indeterminate period of time before becoming fully apparent, and it can progress undiagnosed for years. The mean life expectancy following diagnosis is approximately seven years. Fewer than three percent of individuals live more than fourteen years after diagnosis.

The active ingredient in marijuana may stall decline from Alzheimer’s disease, research suggests. Scientists showed a synthetic version of the compound may reduce inflammation associated with Alzheimer’s and thus help to prevent mental decline. They hope the cannabinoid may be used to developed new drug therapies. The research, by Madrid’s Complutense University and the Cajal Institute, is published in the Journal of Neuroscience.

 
Get Certified Today
Fill Out & eSign the Medical Release Form to Start Your Certification Process:
 
First Name:
Last Name:
Phone:
E-mail:
 
 
Certification RENEWALS
Fill Out & E-Sign Our Renewal Form.
 
AZMMCC Scottsdale
10435 N. Scottsdale Road
Scottsdale, AZ 85253
Phone: 480-994-0420
Fax: 855-305-3152
Email: info@azmmcc.com
Map & Directions
AZMMCC Tucson
North First Medical Plaza,
4745 N. 1st Avenue, Tucson, AZ 85718
Phone: 520-441-7420
Fax: 520-441-7410
Email: info@azmmcc.com
Map & Directions
AZMMCC Cottonwood
830 S Main St.
Suite 1-F
Cottonwood Financial Center
Cottonwood, AZ 86326
Phone: 928-399-7850
Fax: 855-305-4152
Email: info@azmmcc.com
Map & Directions
 
AZMMCC Flagstaff
In the 4th Street Professional Building,
2501 North 4th Street - Suite 16B,
Flagstaff, Arizona 86004
Phone: 928-399-7950
Fax: 928-255-5271
Email: info@azmmcc.com
Map & Directions
AZMMCC Phoenix
Phone: 602-761-9580
Email: info@azmmcc.com
AZMMCC Sierra Vista
Phone: 520-441-0420
Email: info@azmmcc.com
AZMMCC Sun City
NEW LOCATION COMING SOON
Phone: 623-321-5070
Email: info@azmmcc.com
NEW WEST SIDE LOCATION
AZMMCC GLENDALE
5405 W. Glendale Ave.
Glendale Az. 85301
Phone: 623-321-5070
Email: info@azmmcc.com
AZMMCC Wickenburg
Phone: 928-399-7850
Email: info@azmmcc.com